Skip to main content

Table 1 Maternal and fetal characteristics of twins according to delivery indications

From: Perinatal outcomes in twin late preterm pregnancies: results from an Italian area-based, prospective cohort study

 

Spontaneous n 85 (24.6%)

P PROM n 66 (19.1%)

Indicated n: 117 (33.8%)

No indicated n: 78 (22.5%)

Total n: 346

P

Mean maternal age

32 ± 5.6

33.8 ± 5.9

34.7 ± 5.7

34.6 ± 5.8

33.9 ± 5.8

<  0.01+

Primiparity

38 (44.7)

27 (40.9)

51 (43.6)

41 (52.6)

157 (45.4)

0.5*

Chorionicity

Bichorial-biamniotic

66 (77.6)

57 (86.4)

61 (52.1)

78 (100)

262 (75.7)

<  0.01**

Monochorial-biamniotic

19 (22.4)

9 (13.6)

53 (45.3)

0

81 (23.4)

Monochorial-monoamniotic

0

0

3 (6)

0

3 (0.9)

Previous spontaneous PTB

5 (5.9)

0

1 (0.8)

3 (3.8)

9 (2.6)

0.06**

Gestational age

34–34 + 6 weeks

23 (27.1)

14 (21.2)

24 (20.5)

12 (15.4)

73 (21.1)

<  0.01*

35–35 + 6 weeks

33 (38.8)

26 (39.4)

35 (29.9)

16 (20.5)

110 (31.8)

36–36 + 6 weeks

29 (34.1)

26 (39.4)

58 (49.6)

50 (64.1)

163 (47.1)

Race

Non caucasian

26 (30.6)

12 (18.2)

23 (19.7)

10 (12.8)

71 (20.5)

0.04*

Low education (<  8 years)

25 (29.4)

18 (27.3)

27 (23.1)

13(16.7)

83 (24)

0.2*

BMI

22.1 (20.2–27.3)

22.7 (20.2–26.9)

22.9 (20.3–25.8)

21.8 (19.8–25.7)

22.4 (20.2–26.2)

0.6§

Obesity

14 (16.9)

12 (18.7)

16 (14)

7 (9)

49 (14.4)

0.3*

Excessive Weight Gain (IOM)

10 (17.5)

6 (15)

13 (16.2)

4 (6.8)

33 (14)

0.3**

Smoking habit

Smoking

6 (7.2)

9 (13.6)

9 (8)

12 (15.4)

36 (10.6)

0.2*

Assisted reproductive technologies

18 (21.2)

12 (18.2)

30 (25.6)

32 (41)

92 (26.6)

<  0.01*

Diabetes

Pregestational diabetes

0

0

1 (0.8)

0

1 (0.3)

<  0.09**

Class A2 GDM

1 (1.2)

3 (4.5)

7 (6)

0

11 (3.2)

Class A1 GDM

6 (7)

2 (3)

12 (10.3)

4 (5.1)

24 (6.9)

No diabetes

78 (91.8)

61 (92.5)

97 (82.9)

74 (94.9)

310 (89.6)

Hypertensive disorders

Chronic Hypertension

0

0

1 (0.9)

2(2.6)

3 (0.9)

<  0.01 **

Preeclampsia/ Gestational

0

5 (7.6)

33 (28.2)

0

38 (11)

Hypertension

85 (100)

61 (92.4)

83 (70.9)

76 (97.4)

305 (88.1)

Normotensive

     

Vaginal bleeding (Abruption/Placenta previa)

1 (1.2)

2 (3)

13 (11)

0

16 (4.6)

< 0.01**

Liver disorders

5 (5.9)

6 (9.1)

4 (3.4)

5 (6.4)

20 (5.8)

0.04 **

Twin to twin transfusion syndrome

0

0

3 (2.4)

0

3 (0.9)

0.3**

Clinical chorioamnionitis

4 (4.7)

2 (3)

0

0

6 (1.7)

0.01**

Type of labor

No labour

0

41 (62.1)

97 (82.9)

66 (84.6)

204 (58.9)

< 0.01**

Induced labour

0

5 (7.6)

20 (17.1)

12 (15.4)

37 (10.7)

Spontaneous labour

85 (100)

20 (30.3)

0

0

105 (30.4)

Mode of delivery

Vaginal

23 (27.1)

11 (16.7)

12 (10.3)

7 (9)

53 (15.3)

< 0.01**

Cesarean in labour

62 (72.9)

14 (21.2)

8 (6.8)

5 (6.4)

89 (26)

Cesarean non in labour

0

41 (62.1)

97 (82.9)

66 (84.6)

204 (58.7)

Antenatal corticosteroids

No steroids

50 (58.8)

29 (43.9)

91 (77.8)

45 (57.7)

215 (62.1)

< 0.01*

ASA prophylaxis

5 (5.9)

4 (6.1)

6 (5.1)

4 (5.1)

19 (5.5)

0.9**

LMWH prophylaxis

4 (4.4)

3 (4.5)

3 (2.6)

3 (3.8)

13 (3.8)

0.8**

Progesterone Prophylaxis

10 (15.3)

4 (6.1)

13 (11.1)

10 (14.8)

40 (11.6)

0.3**

Non reassuring fetal monitoring (category III)

2 (2.3)

2 (3)

5 (4.3)

0

9 (2.6)

0.3**

Fetal Growth restriction (FGR)

3 (3.5)

0

30 (25.6)

0

33 (9.5)

< 0,01**

Fetal anomalies

None

82 (96.5)

66 (100)

112 (95.7)

78

338 (97.7)

0.8**

Cardiovascular

2 (2.3)

0

3 (2.5)

0

5 (1.4)

 

CNS

1 (1.2)

0

0

0

1 (0.3)

 

Gastrointestinal

0

0

1 (0.9)

0

1 (0.3)

 

Genito-urinary

0

0

1 (0.9)

0

1 (0.3)

 

Amniotic fluid anomalies

Oligo/anidramnios

1 (1.2)

0

2 (1.8)

0

3 (0.9)

0.8**

Polidramnios

1 (1.2)

0

1 (0.9)

0

2 (0.6)

Normal

83 (97.6)

66 (100)

114 (97.3)

78 (100)

341 (98.5)

  1. Low education: primary and secondary school; Excessive Weight Gain: above IOM guidelines per BMI category; Previous PTB: prior birth < 37 weeks; Class A1 GDM: diet, Class A2 GDM: Insulin therapy; Non reassuring fetal monitoring: category III tracing according to ACOG
  2. *Chi square test
  3. ** Fisher Exact test
  4. §ANOVA on ranks, + ANOVA